These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 28367651)

  • 1. Outcomes in an obstetrical population with hereditary thrombophilia and high tobacco use.
    Calhoun B; Hoover E; Seybold D; Broce M; Hill A; Schaible B; Bracero LA
    J Matern Fetal Neonatal Med; 2018 May; 31(10):1267-1271. PubMed ID: 28367651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of anticoagulant therapy on pregnancy outcomes in patients with thrombophilia and previous poor obstetric history.
    Mutlu I; Mutlu MF; Biri A; Bulut B; Erdem M; Erdem A
    Blood Coagul Fibrinolysis; 2015 Apr; 26(3):267-73. PubMed ID: 25268607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-molecular-weight heparin plus aspirin versus aspirin alone in pregnant women with hereditary thrombophilia to improve live birth rate: meta-analysis of randomized controlled trials.
    Areia AL; Fonseca E; Areia M; Moura P
    Arch Gynecol Obstet; 2016 Jan; 293(1):81-86. PubMed ID: 26059084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does low-molecular-weight heparin influence fetal growth or uterine and umbilical arterial Doppler in women with a history of early-onset uteroplacental insufficiency and an inheritable thrombophilia? Secondary randomised controlled trial results.
    Abheiden C; Van Hoorn ME; Hague WM; Kostense PJ; van Pampus MG; de Vries J
    BJOG; 2016 Apr; 123(5):797-805. PubMed ID: 26036190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-pregnant circulatory volume status predicts subsequent pregnancy outcome in normotensive thrombophilic formerly preeclamptic women.
    Spaanderman ME; Aardenburg R; Ekhart TH; van Eyndhoven HW; van der Heijden OW; van Eyck J; de Leeuw PW; Peeters LL
    Eur J Obstet Gynecol Reprod Biol; 2001 Apr; 95(2):218-21. PubMed ID: 11301175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiphospholipid antibody profile based obstetric outcomes of primary antiphospholipid syndrome: the PREGNANTS study.
    Saccone G; Berghella V; Maruotti GM; Ghi T; Rizzo G; Simonazzi G; Rizzo N; Facchinetti F; Dall'Asta A; Visentin S; Sarno L; Xodo S; Bernabini D; Monari F; Roman A; Eke AC; Hoxha A; Ruffatti A; Schuit E; Martinelli P;
    Am J Obstet Gynecol; 2017 May; 216(5):525.e1-525.e12. PubMed ID: 28153662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-molecular-weight heparin combined with aspirin in pregnant women with thrombophilia and a history of preeclampsia or fetal growth restriction: a preliminary study.
    Riyazi N; Leeda M; de Vries JI; Huijgens PC; van Geijn HP; Dekker GA
    Eur J Obstet Gynecol Reprod Biol; 1998 Sep; 80(1):49-54. PubMed ID: 9758259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of adverse perinatal outcome in inherited thrombophilias: a clinical study.
    Kosar A; Kasapoglu B; Kalyoncu S; Turan H; Balcik OS; Gümüs EI
    Blood Coagul Fibrinolysis; 2011 Jan; 22(1):14-8. PubMed ID: 21042205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-molecular-weight heparin for prevention of preeclampsia and other placenta-mediated complications: a systematic review and meta-analysis.
    Cruz-Lemini M; Vázquez JC; Ullmo J; Llurba E
    Am J Obstet Gynecol; 2022 Feb; 226(2S):S1126-S1144.e17. PubMed ID: 34301348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aspirin, low molecular weight heparin, or both in preventing pregnancy complications in women with recurrent pregnancy loss and factor V Leiden mutation.
    Karadağ C; Akar B; Gönenç G; Aslancan R; Yılmaz N; Çalışkan E
    J Matern Fetal Neonatal Med; 2020 Jun; 33(11):1934-1939. PubMed ID: 31550962
    [No Abstract]   [Full Text] [Related]  

  • 11. Aspirin or anticoagulants for treating recurrent miscarriage in women without antiphospholipid syndrome.
    Kaandorp S; Di Nisio M; Goddijn M; Middeldorp S
    Cochrane Database Syst Rev; 2009 Jan; (1):CD004734. PubMed ID: 19160241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of aspirin, heparin, and other interventions in the prevention and treatment of fetal growth restriction.
    Groom KM; David AL
    Am J Obstet Gynecol; 2018 Feb; 218(2S):S829-S840. PubMed ID: 29229321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-molecular-weight heparin for the prevention of preeclampsia in high-risk pregnancies without thrombophilia: a systematic review and meta-analysis.
    Chen J; Huai J; Yang H
    BMC Pregnancy Childbirth; 2024 Jan; 24(1):68. PubMed ID: 38233773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low molecular weight heparin versus no treatment in women with previous severe pregnancy complications and placental findings without thrombophilia.
    Kupferminc M; Rimon E; Many A; Maslovitz S; Lessing JB; Gamzu R
    Blood Coagul Fibrinolysis; 2011 Mar; 22(2):123-6. PubMed ID: 21192252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High frequency of congenital thrombophilia in women with pathological pregnancies?
    Rasmussen A; Ravn P
    Acta Obstet Gynecol Scand; 2004 Sep; 83(9):808-17. PubMed ID: 15315591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low molecular weight heparin treatment and impact of inherited thrombophilia type in pregnancies with previous adverse outcome.
    Aracic N; Roje D; Drmic Hofman I; Capkun V; Stefanovic V
    J Matern Fetal Neonatal Med; 2015 Feb; 28(3):306-10. PubMed ID: 24749801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pre-pregnant prediction of recurrent preeclampsia in normotensive thrombophilic formerly preeclamptic women receiving prophylactic antithrombotic medication.
    Spaanderman ME; Aardenburg R; Ekhart TH; van Eyndhoven HW; de Leeuw PW; Peeters LL
    J Soc Gynecol Investig; 2005 Feb; 12(2):112-7. PubMed ID: 15695106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. THE ROLE OF LOW MOLECULAR WEIGHT HEPARIN IN WOMEN WITH HEREDITARY THROMBOPHILIA FOR GOOD PERINATAL OUTCOME.
    Sokol V; Ivanišević M; Herman M; Đelmiš J
    Acta Clin Croat; 2016 Jun; 55(2):309-15. PubMed ID: 28394549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Impact of Inherited Thrombophilia Types and Low Molecular Weight Heparin Treatment on Pregnancy Complications in Women with Previous Adverse Outcome.
    Aracic N; Roje D; Jakus IA; Bakotin M; Stefanovic V
    Yonsei Med J; 2016 Sep; 57(5):1230-5. PubMed ID: 27401656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of 2 approaches in management of pregnant women with inherited trombophilias: Prospective analytical cohort study.
    Dugalic S; Petronijevic M; Stefanovic A; Stefanovic K; Petronijevic SV; Stanisavljevic D; Kepeci SP; Milincic N; Pantic I; Perovic M
    Medicine (Baltimore); 2019 Aug; 98(34):e16883. PubMed ID: 31441864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.